PORT HURON, MI -- (MARKET WIRE) -- 02/15/2006 -- China Northwest Biotech Corp. (OTC: CNWB ) announced today that the company will begin trading at the opening of the markets today, February 15th, 2006 under the new ticker symbol (OTC: CNWB ). China Northwest Biotech is a manufacturer of a line of all natural herbal medicines.
"This new symbol is the final step for us to complete the merger between AVL Global (OTC: AVLL ) and The Chong Yang Group," states CEO Michael Dooley "The new symbol better reflects the companies current operation as a leader in the natural products industry."
Recently, China Northwest Biotech signed a major distribution agreement with Reliant International Group Ltd., a direct distributor and manufacturer of all natural products. Reliant International will join China Northwest to assist in developing their products and packaging in the United States, which are now selling only in the greater China territories.
About China Northwest Biotech Corp. (CNWB)
China Northwest Biotech Corp. is a manufacturer of a line of all natural herbal medicines with full GMP certification. Their leading product is a liver stabilization drink that helps maintain a healthy liver and assists in slowing down the degenerative effects of various forms of liver disease. They are currently expanding to the technology sector through a partnership with Electro-Dynamic Research Group. More information is available at the company's website: www.ChinaNWBiotech.com
